Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2018-12-12
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study
NCT03331458
Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer
NCT02334579
Exercise for Prostate Cancer Patients
NCT00815672
Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation Therapy
NCT00308919
Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers
NCT03961737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention light
30 minutes of intervention systematic light exposure daily for the course of radiation therapy (approximately 8 weeks).
Intervention systematic light exposure
30 minutes of intervention systematic light exposure daily
Comparison light
30 minutes of comparison systematic light exposure daily for the course of radiation therapy (approximately 8 weeks).
Comparison systematic light exposure
30 minutes of comparison systematic light exposure daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention systematic light exposure
30 minutes of intervention systematic light exposure daily
Comparison systematic light exposure
30 minutes of comparison systematic light exposure daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are about to begin external beam radiation therapy (RT) for prostate cancer,
* Are 18 years of age or older,
* Are able to speak or read English,
* Have internet access.
Exclusion Criteria
* Active infection
* History of chronic fatigue disorders
* Confounding underlying medical illnesses such as significant pre-existing anemia (Hb\<10 gm/dl)
* Diagnosed or suspected psychiatric or medical condition that might contribute to fatigue (other than those caused by the cancer or its treatment)
* Hypothyroidism or documented history of hypothyroidism on thyroid replacement hormone within \<3 months of initiating RT
* History of bipolar disorder or mania
* History of seasonal affective disorder
* Diagnosed sleep apnea, restless legs, or other sleep disorders (not including insomnia) known to affect fatigue
* Use of photosensitizing medication
* Plans to travel across more than 2 time zones during the study
* Shift worker
* Adults unable to consent, individuals who are not yet adults, pregnant women, and prisoners will be excluded from the study
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa M. Wu
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa M Wu, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern Univeristy Feinberg School of Medicine
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00205260
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.